Viewing nowCombinationLinatop Duo Tablets 2.5/1000 mg (Linagliptin, Metformin Hydrochloride)
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 201904459 · Approved 2019.06.28 · Insurance code 657308930
Improves blood glucose control in patients with type 2 diabetes mellitus
This drug helps patients with type 2 diabetes to more effectively control blood sugar levels along with diet and exercise therapy. It is used to enhance blood sugar control through the combined administration of Linagliptin and Metformin.
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of each component: linagliptin 2.5 mg and metformin 1000 mg twice daily. This medicine is administered twice daily with meals. To reduce gastrointestinal adverse reactions associated with metformin use, the dose should be increased gradually. 1. Patients not currently receiving metformin: For patients with no prior experience of antidiabetic drug therapy who do not achieve adequate glycemic control with monotherapy, the starting dose of this medicine is 1 tablet of 2.5/500 mg twice daily. The dose may be increased to 1 tablet of 2.5/1000 mg twice daily. 2. Patients unable to achieve adequate glycemic control with metformin monotherapy: The starting dose of this medicine should be linagliptin 2.5 mg twice daily (total daily dose 5 mg) and the patient's current metformin dose (e.g., a patient taking metformin 1000 mg twice daily should take linagliptin 2.5 mg/metformin 1000 mg twice daily with meals). 3. Switching from combination therapy with linagliptin and metformin: Patients switching from combination therapy with linagliptin and metformin to this medicine should start at their current doses of linagliptin and metformin. 4. Patients unable to achieve adequate glycemic control with combination therapy of metformin and a sulfonylurea: The starting dose of this medicine should be considered to be linagliptin 2.5 mg twice daily (total daily dose 5 mg) and a dose similar to the patient's current metformin dose. When this medicine is administered in combination with a sulfonylurea, a reduction in the sulfonylurea dose may be necessary to reduce the risk of hypoglycemia (see Precautions for Use, 3. Administration with Caution in the Following Patients). 5. Patients unable to achieve adequate glycemic control with combination therapy of insulin and metformin: The starting dose of this medicine should be considered to be linagliptin 2.5 mg twice daily (total daily dose 5 mg) and a dose similar to the patient's current metformin dose. When this medicine is administered in combination with insulin, a reduction in the insulin dose may be necessary to reduce the risk of hypoglycemia (see Precautions for Use, 3. Administration with Caution in the Following Patients). No studies have been conducted to evaluate the safety and efficacy of switching to this medicine in patients previously treated with other oral antihyperglycemic agents. Any change in the treatment regimen for type 2 diabetes may result in a change in glycemic control; caution should therefore be exercised and appropriate monitoring should be performed. Patients with renal impairment This medicine may be used in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] 45≤~<60 ml/min or estimated glomerular filtration rate (eGFR) 45≤~<60 mL/min/1.73 m2), who have no other condition that may increase the risk of lactic acidosis, with the following dose adjustment. Since the starting dose of metformin is 500mg or 850mg once daily, treatment should not be initiated with this medicine. The maximum recommended dose of metformin is 500 mg twice daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately. Patients with hepatic impairment This medicine should not be administered to patients with hepatic impairment because it contains metformin (see Precautions for Use, 2. Do Not Administer to the Following Patients).
This medication helps control blood sugar. However, it can cause a rare but serious side effect called lactic acidosis, so it should not be administered to patients with impaired kidney function or certain heart diseases and liver dysfunction. Patients who are allergic to the components of this medication, or those with type 1 diabetes, acute myocardial infarction, should also not use it. Additionally, women who are pregnant or breastfeeding should not take this medication. Due to the risk of hypoglycemia, caution is necessary when used in conjunction with insulin or sulfonylureas, and dosage adjustments may be required. Caution should also be exercised in elderly patients with impaired kidney function or those taking medications that may affect kidney function. In situations that can cause rapid changes in kidney function, such as acute infections, dehydration, severe trauma, or pre-and post-surgery, the use of this drug should be temporarily suspended. If iodinated contrast agents used in radiological examinations are to be administered, this medication should also be temporarily stopped before and after the examination, and renal function should be monitored. Gastrointestinal disturbances (abdominal pain, diarrhea, vomiting, etc.) may occur at the beginning of treatment, but they usually improve over time. Additionally, since a deficiency of vitamin B12 may occur, it's advisable to monitor blood vitamin B12 levels during long-term use. If symptoms of acute pancreatitis or bullous pemphigoid (blister formation on the skin) appear, discontinuation of the medication should be immediate and consultation with a physician is necessary. This medication is not recommended for children and pediatric patients under 10 years of age, and elderly patients should be administered the minimum dosage while regularly monitoring kidney function. In cases of overdose, the risk of lactic acidosis is present, requiring immediate treatment, and blood dialysis is an effective treatment method. This medication should be kept out of reach of children, stored away from moisture, and should not be transferred to another container. Lastly, alcohol consumption should be avoided as it may increase the risk of lactic acidosis, and if you are taking other medications that may interact with this medication, consult a physician or pharmacist.
Lactic acidosis, hypoglycemia, taste disturbance, cough, appetite loss, diarrhea, constipation, nausea, pancreatitis, vomiting, abdominal pain, oral ulcer formation, abnormal liver function tests, hepatitis, pruritus, erythema, rash, bullous pemphigoid, severe pain in joints accompanied by disability, rhabdomyolysis, increased lipase, increased amylase, nasopharyngitis, hypersensitivity, angioedema, urticaria, decrease and deficiency of vitamin B12, oral ulcers, constipation, upper abdominal pain, enterocolitis, intestinal obstruction, gastroenteritis, shingles, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, appetite loss, dehydration, hyperglycemia, cerebral infarction, speech disorders, Alzheimer’s dementia, chest pain, fever, facial swelling, fatigue, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscus injury, pneumoconiosis, congestive heart failure, angina, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, kidney transplant failure, anxiety, mood disorder, insomnia, depression, contusion, bone contusion, concussion, bone fracture, hand fracture, palpitations, dry eye, glaucoma, cataract, ocular discomfort, allergic conjunctivitis, polyuria, proteinuria, stress urinary incontinence, hematuria, hypotension, flushing, hepatic steatosis, cholelithiasis, hearing loss, erectile dysfunction, thyroid enlargement, confusion, nocturia, dermatitis, hypertension, itching, angina, acute myocardial infarction, unstable angina, diarrhea, stomatitis, mediastinitis, vitreous hemorrhage, fever, ligament sprain, flank pain, myelodysplastic syndrome, vocal cord polyp, dyspepsia, anal bleeding, cheilitis, dental caries, enteritis, gastritis, stomatitis, increased blood creatinine, facial swelling, hyperthermia, back pain, osteoarthritis, limb pain, rotator cuff syndrome, headache, subdural hygroma, palpitations
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain the storage temperature between 1 to 30 degrees Celsius at room temperature to preserve the efficacy and safety of the drug for a longer period.
Bright pink oval film-coated tablets
60 tablets (10 tablets/PTP x 6)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Anguk Pharm Co., Ltd.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kukje Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.